Attention NHLBI SBIR/STTR Phase II companies, The NIH Commercialization Accelerator Program (CAP) is now accepting applications The deadline for submitting…
Rachel King, co-Founder and Chief Executive Officer of GlycoMimetics, Inc., testified today on behalf of the Biotechnology Innovation Organization (BIO)…
When: Wednesday, October 17, 2018 8:00AM-5:00PM Where: Inova Center for Personalized Health 3225 Gallows Rd Fairfax, Virginia 22037 United States Women of…